Krinsky made chair of Teva Japan and South Korea
This article was originally published in Scrip
Teva has named Itzhak Krinsky chair of Teva Japan and Teva South Korea and head of Asia-Pacific business development effective mid-October. Professor Krinsky is currently Teva’s executive vice-president of corporate business development. He replaces Moshe Manor, who has retired as president and CEO of Teva Asia-Pacific.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.